Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT00689104
Status:
COMPLETED
Last Update Posted:
2024-11-20
First Post:
2008-05-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04-28
Start Date Type:
ACTUAL
Primary Completion Date:
2009-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-29
First Submit QC Date:
None
Study First Post Date:
2008-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-07-17
Results First Submit QC Date:
None
Results First Post Date:
2012-10-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-03-25
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-10-29
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL